How brain immune cells (microglia) and the INPP5D gene affect Alzheimer's

Probing Heterogeneity of Alzheimer's Disease Using iPSCs

NIH-funded research Brigham and Women's Hospital · NIH-11332465

Researchers use patient-derived stem cells to learn how changes in a microglia gene called INPP5D may influence Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11332465 on NIH RePORTER

What this research studies

From my perspective as a patient, the team takes blood or skin cells and turns them into stem cells that are then made into microglia, the brain's immune cells, to model Alzheimer's-related changes. They lower INPP5D activity using gene editing and drugs to see how microglia behavior and inflammatory pathways change. The researchers profile RNA and proteins and compare findings to human Alzheimer's brain samples to link lab results to the real disease. Their focus is on inflammasome activation and other immune signals that could drive brain damage in late‑onset Alzheimer's.

Who could benefit from this research

Good fit: Ideal candidates would be adults with late‑onset Alzheimer's or older adults at increased genetic risk who can donate blood or skin samples for iPSC generation.

Not a fit: People with non‑Alzheimer dementias or those seeking immediate treatment are unlikely to receive direct clinical benefit from this laboratory research.

Why it matters

Potential benefit: If successful, this work could reveal new immune-related targets for drugs that slow or change Alzheimer's progression.

How similar studies have performed: Related studies using iPSC-derived microglia and gene editing have provided mechanistic insights into microglial roles in Alzheimer's, but translating these findings into treatments remains early.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.